Your browser doesn't support javascript.
loading
High mortality rate in COVID-19 patients with myeloproliferative neoplasms after abrupt withdrawal of ruxolitinib.
Barbui, Tiziano; Vannucchi, Alessandro Maria; Alvarez-Larran, Alberto; Iurlo, Alessandra; Masciulli, Arianna; Carobbio, Alessandra; Ghirardi, Arianna; Ferrari, Alberto; Rossi, Giuseppe; Elli, Elena; Andrade-Campos, Marcio Miguel; Kabat, Mercedes Gasior; Kiladjian, Jean-Jaques; Palandri, Francesca; Benevolo, Giulia; Garcia-Gutierrez, Valentin; Fox, Maria Laura; Foncillas, Maria Angeles; Morcillo, Carmen Montoya; Rumi, Elisa; Osorio, Santiago; Papadopoulos, Petros; Bonifacio, Massimiliano; Cervantes, Keina Susana Quiroz; Serrano, Miguel Sagues; Carreno-Tarragona, Gonzalo; Sobas, Marta Anna; Lunghi, Francesca; Patriarca, Andrea; Elorza, Begona Navas; Angona, Anna; Mazo, Elena Magro; Koschmieder, Steffen; Ruggeri, Marco; Cuevas, Beatriz; Hernandez-Boluda, Juan Carlos; Abadia, Emma Lopez; Cirici, Blanca Xicoy; Guglielmelli, Paola; Garrote, Marta; Cattaneo, Daniele; Daffini, Rosa; Cavalca, Fabrizio; Bellosillo, Beatriz; Benajiba, Lina; Curto-Garcia, Natalia; Bellini, Marta; Betti, Silvia; De Stefano, Valerio; Harrison, Claire.
Afiliación
  • Barbui T; FROM Research Foundation, Papa Giovanni XXIII Hospital, Bergamo, Italy. tbarbui@fondazionefrom.it.
  • Vannucchi AM; Center Research and Innovation of Myeloproliferative Neoplasms (CRIMM), Department of Experimental and Clinical Medicine, Azienda Ospedaliera Universitaria Careggi, University of Florence, Florence, Italy.
  • Alvarez-Larran A; Hospital Clinic de Barcelona, Barcelona, Spain.
  • Iurlo A; Hematology Division, Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.
  • Masciulli A; FROM Research Foundation, Papa Giovanni XXIII Hospital, Bergamo, Italy.
  • Carobbio A; FROM Research Foundation, Papa Giovanni XXIII Hospital, Bergamo, Italy.
  • Ghirardi A; FROM Research Foundation, Papa Giovanni XXIII Hospital, Bergamo, Italy.
  • Ferrari A; FROM Research Foundation, Papa Giovanni XXIII Hospital, Bergamo, Italy.
  • Rossi G; Spedali Civili, Brescia, Italy.
  • Elli E; Ospedale San Gerardo, ASST Monza, Monza, Italy.
  • Andrade-Campos MM; Hospital del Mar, Barcelona, Spain.
  • Kabat MG; Hospital Universitario la Paz, Madrid, Spain.
  • Kiladjian JJ; Hospital Saint-Louis, Paris, France.
  • Palandri F; Azienda Ospedaliero-Universitaria di Bologna, Via Albertoni 15, Bologna, Italia.
  • Benevolo G; AOU Città della Salute e della Scienza di Torino, Torino, Italy.
  • Garcia-Gutierrez V; Hospital Ramon y Cajal, IRYCIS, Madrid, Spain.
  • Fox ML; Department of Hematology, Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Hospital Universitari, Vall d'Hebron Barcelona Hospital Campus, C/ Natzaret, 115-117, 08035, Barcelona, Spain.
  • Foncillas MA; Hospital Universitario Infanta Leonor, Madrid, Spain.
  • Morcillo CM; Hospital General Universitario de Albacete, Albacete, Spain.
  • Rumi E; Department of Molecular Medicine, University of Pavia, Pavia, Italy.
  • Osorio S; Hospital Gregorio Maranon, Madrid, Spain.
  • Papadopoulos P; Hospital Clinico San Carlos, Madrid, Spain.
  • Bonifacio M; Ospedale Policlinico "G.B. Rossi", Borgo Roma, Verona, Italy.
  • Cervantes KSQ; Hospital Universitario de Mostoles, Madrid, Spain.
  • Serrano MS; ICO L'Hospitalet-Hospital Moises Broggi, Sant Joan Despì, Barcelona, Spain.
  • Carreno-Tarragona G; Hospital Universitario 12 de Octubre, Madrid, Spain.
  • Sobas MA; Department of Hematology, Blood Neoplasms and Bone Marrow Transplantation, Wroclaw Medical University, Wroclaw, Poland.
  • Lunghi F; IRCCS Ospedale San Raffaele, Milano, Italy.
  • Patriarca A; AOU Maggiore della Carità, Novara, Italy.
  • Elorza BN; Hospital Moncloa, Madrid, Spain.
  • Angona A; ICO Girona Hospital Josep Trueta, Girona, Spain.
  • Mazo EM; Hospital Universitario Principe de Asturias, Alcalà de Henares, Madrid, Spain.
  • Koschmieder S; Department of Hematology, Oncology, Hemostaseology, and Stem Cell Transplantation, Faculty of Medicine, RWTH Aachen University, Aachen, Germany.
  • Ruggeri M; Ospedale San Bortolo, Vicenza, Italy.
  • Cuevas B; Hospital Universitario de Burgos, Burgos, Spain.
  • Hernandez-Boluda JC; Hospital Clinico Universitario, INCLIVA, Valencia, Spain.
  • Abadia EL; Hospital General de Elche, Elche (Alicante), Spain.
  • Cirici BX; Hospital Germans Trias i Pujol, Badalona (Barcelona), Spain.
  • Guglielmelli P; Center Research and Innovation of Myeloproliferative Neoplasms (CRIMM), Department of Experimental and Clinical Medicine, Azienda Ospedaliera Universitaria Careggi, University of Florence, Florence, Italy.
  • Garrote M; Hospital Clinic de Barcelona, Barcelona, Spain.
  • Cattaneo D; Hematology Division, Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.
  • Daffini R; Spedali Civili, Brescia, Italy.
  • Cavalca F; Ospedale San Gerardo, ASST Monza, Monza, Italy.
  • Bellosillo B; Hospital del Mar, Barcelona, Spain.
  • Benajiba L; Hospital Saint-Louis, Paris, France.
  • Curto-Garcia N; Guy's and St. Thomas' NHS Foundation Trust, London, UK.
  • Bellini M; ASST Papa Giovanni XXIII, Bergamo, Italy.
  • Betti S; Fondazione Policlinico "A. Gemelli" IRCCS, Rome, Italy.
  • De Stefano V; Fondazione Policlinico "A. Gemelli" IRCCS, Rome, Italy.
  • Harrison C; Guy's and St. Thomas' NHS Foundation Trust, London, UK.
Leukemia ; 35(2): 485-493, 2021 02.
Article en En | MEDLINE | ID: mdl-33414483
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Pirazoles / Privación de Tratamiento / SARS-CoV-2 / COVID-19 / Trastornos Mieloproliferativos Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Aged / Female / Humans / Male / Middle aged País/Región como asunto: Europa Idioma: En Revista: Leukemia Asunto de la revista: HEMATOLOGIA / NEOPLASIAS Año: 2021 Tipo del documento: Article País de afiliación: Italia
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Pirazoles / Privación de Tratamiento / SARS-CoV-2 / COVID-19 / Trastornos Mieloproliferativos Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Aged / Female / Humans / Male / Middle aged País/Región como asunto: Europa Idioma: En Revista: Leukemia Asunto de la revista: HEMATOLOGIA / NEOPLASIAS Año: 2021 Tipo del documento: Article País de afiliación: Italia